REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the "Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Verisure’s majority owner Hellman & Friedman has lined up more banks for a potential initial public offering of the security ...
Fourth Quarter and Full Year 2024 Financial Results Conference Call Date: March 24, 2025 Time: 4:30 p.m. ET Live Call: 1-800-245-3047 (U.S. Toll Free) or 1-203-518-9765 (International) Webcast: Events ...
Private equity funds that own German drugmaker Stada Arzneimittel AG have decided to postpone its planned initial public ...
A broad coalition of civil society is calling on governments around the world to take urgent action to protect forests as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback